MedPath

A Japanese early phase 2 study of S-444823 ointment in patients with atopic dermatitis

Phase 2
Conditions
Atopic Dermatitis
Registration Number
JPRN-jRCT2080220964
Lead Sponsor
SHIONOGI & CO., LTD.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
230
Inclusion Criteria

Patient satisfies the diagnostic criteria for AD as defined by the criteria of Hanifin & Rajka, etc.

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath